Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/6/26 20:00 | 1/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Thompson Travis Alvin | X0 | O | Chief Ac | 1 | S.dm | -16 | 6.64 | 0 | -2 | 66 | D | |||||||||||||||
1/6/26 20:00 | 1/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Skynner Michael | X0 | O | CTO | 1 | S.dm | -42 | 6.62 | 0 | -6 | 162 | D | |||||||||||||||
1/6/26 20:00 | 1/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Hannay Michael Charles Ferguson | X0 | O | CHIEF PR | 1 | S.dm | -34 | 6.64 | 0 | -5 | 98 | D | |||||||||||||||
1/6/26 20:00 | 1/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Milnes Alistair | X0 | O | COO | 1 | S.dm | -44 | 6.63 | 0 | -7 | 137 | D | |||||||||||||||
1/6/26 20:00 | 1/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Young Alethia | X0 | O | CFO | 1 | S.dm | -50 | 6.62 | 0 | -8 | 87 | D | |||||||||||||||
1/6/26 20:00 | 1/2/26 | BCYC | Health | Drug | Pharmaceutical Preparations | Lee Kevin | X0 | DO | CEO | 1 | S.dm | -141 | 6.62 | 0 | -21 | 619 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |